Skip to main
RVTY
RVTY logo

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 45%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

Revvity's stock outlook appears positive due to its robust growth trajectory, driven by strategic transitions in the market and an evolving product portfolio. The company benefits from a diversified mix of high-margin businesses, including its software segment, Signals, and its leading positions in life science reagents and immunodiagnostics, which have collectively positioned it for above-market growth in key areas such as autoimmune testing. Additionally, ongoing margin improvements and operational efficiencies indicate a higher profitability potential, enhancing Revvity's overall financial profile and market competitiveness.

Bears say

Revvity's stock outlook is negatively impacted by significant revenue declines in its China segment, particularly in Immunodiagnostics, which experienced a double-digit percentage drop in the second quarter of 2025 and is projected to contribute less than 5% of total revenue by 2026. Furthermore, broader economic conditions, including industry funding cuts, pose risks to customer demand, which could adversely affect Revvity's market share and overall financial performance. Additionally, potential macroeconomic changes such as product shortages, inflation, and labor challenges may disrupt the company's supply chain, further complicating its operational delivery and growth prospects.

Revvity Inc (RVTY) has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 45% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Buy based on their latest research and market trends.

According to 11 analysts, Revvity Inc (RVTY) has a Buy consensus rating as of Dec 17, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $112.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $112.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.